Product selection issues Working group Product selection issues
GF PSM Plans Can the list of medicines be revised once PSM plans have been approved? Introduction of OI drugs (SA) revision of guidelines (EG) latency period with needs in additional ARVs and before guidelines be up-dated What is the process to get the approval from GF? LFA, PR, Port-Folio?
Condoms procurement requirements Clarification needed on WB requirements (Tanzania) How countries in the room have responded to WB requirements of a pre qualified list of manufacturers ?
ARV paediatrics WHO Pre-qualified list: too few paediatric formulations (Uganda) Not registered at country level
Other issues GF: notion of stringent authorities (SA) Clinton Foundation: match between the pricing list and WHO pre-qualified list